Guan Xing

1.1k total citations
40 papers, 661 citations indexed

About

Guan Xing is a scholar working on Genetics, Genetics and Immunology. According to data from OpenAlex, Guan Xing has authored 40 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 11 papers in Genetics and 11 papers in Immunology. Recurrent topics in Guan Xing's work include Chronic Lymphocytic Leukemia Research (17 papers), Genetic Associations and Epidemiology (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Guan Xing is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Genetic Associations and Epidemiology (10 papers) and Lymphoma Diagnosis and Treatment (9 papers). Guan Xing collaborates with scholars based in United States, United Kingdom and France. Guan Xing's co-authors include Chao Xing, Nina D. Wagner‐Johnston, Tadeusz Robak, Stephen Chan, Christine E. Horak, Lyndah Dreiling, Jeffrey A. Jones, Ling‐Ming Tseng, Jennifer R. Brown and Cristina Saura and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Genetics.

In The Last Decade

Guan Xing

40 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guan Xing United States	14	261	200	173	172	169	40	661
W.‐K. Hofmann Germany	15	203 0.8×	248 1.2×	110 0.6×	63 0.4×	194 1.1×	22	905
Hiro Tatetsu Japan	15	123 0.5×	356 1.8×	84 0.5×	125 0.7×	127 0.8×	35	600
Nora Ku United States	11	99 0.4×	128 0.6×	168 1.0×	65 0.4×	250 1.5×	24	584
Yingzhe Yu China	9	117 0.4×	195 1.0×	189 1.1×	79 0.5×	195 1.2×	23	626
Anke K. Bergmann Germany	12	128 0.5×	244 1.2×	77 0.4×	85 0.5×	113 0.7×	34	524
Sandra D. Bohling United States	13	89 0.3×	209 1.0×	211 1.2×	208 1.2×	40 0.2×	22	586
Vasantha Brito‐Babapulle United Kingdom	15	498 1.9×	171 0.9×	233 1.3×	457 2.7×	114 0.7×	29	773
Laure Vincent France	17	136 0.5×	439 2.2×	179 1.0×	94 0.5×	353 2.1×	58	802
Caterina Fusco Italy	11	152 0.6×	114 0.6×	161 0.9×	309 1.8×	71 0.4×	22	616
Ugo Rovigatti United States	10	183 0.7×	224 1.1×	107 0.6×	139 0.8×	251 1.5×	27	713

Countries citing papers authored by Guan Xing

Since Specialization

Citations

This map shows the geographic impact of Guan Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Xing more than expected).

Fields of papers citing papers by Guan Xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guan Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Xing. The network helps show where Guan Xing may publish in the future.

Co-authorship network of co-authors of Guan Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Guan Xing. A scholar is included among the top collaborators of Guan Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guan Xing. Guan Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Wei, Yan Xu, Ying Zeng, & Guan Xing. (2024). A meta-analysis and systematic review based on perioperative management of elderly patients: is ciprofol an alternative to propofol?. European Journal of Clinical Pharmacology. 81(1). 111–121. 2 indexed citations

Aggarwal, Rahul, Alexander Starodub, Brian D. Koh, et al.. (2022). Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(18). 3979–3989. 18 indexed citations

Daver, Naval, Paresh Vyas, Suman Kambhampati, et al.. (2022). AML-464 Tolerability and Efficacy of the First-In-Class Anti-CD47 Antibody Magrolimab Combined With Azacitidine in Frontline Patients With TP53-Mutated Acute Myeloid Leukemia (AML): Phase 1b Results. Clinical Lymphoma Myeloma & Leukemia. 22. S253–S254. 5 indexed citations

Vyas, Paresh, Naval Daver, Mark P. Chao, et al.. (2021). A Phase 2, Open-Label, Multiarm, Multicenter Study to Evaluate Magrolimab Combined with Antileukemia Therapies for First-Line, Relapsed/Refractory, or Maintenance Treatment of Acute Myeloid Leukemia. Blood. 138(Supplement 1). 3424–3424. 2 indexed citations

Daver, Naval, Paresh Vyas, Mark P. Chao, et al.. (2021). A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine in Previously Untreated Patients with TP53-Mutant Acute Myeloid Leukemia. Blood. 138(Supplement 1). 3426–3426. 13 indexed citations

Ma, Shuo, Rebecca J. Chan, Lin Gu, et al.. (2020). Retrospective Analysis of the Impact of Adverse Event–Triggered Idelalisib Interruption and Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies. Clinical Lymphoma Myeloma & Leukemia. 21(5). e432–e448. 11 indexed citations

Wagner‐Johnston, Nina D., Stephen J. Schuster, Sven deVos, et al.. (2020). Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas. Leukemia & lymphoma. 62(5). 1077–1087. 12 indexed citations

Wagner‐Johnston, Nina D., Stephen J. Schuster, Sven de Vos, et al.. (2019). Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia. Blood. 134(Supplement_1). 4006–4006. 4 indexed citations

Jones, Jeffrey A., Tadeusz Robak, Jennifer R. Brown, et al.. (2017). Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial. The Lancet Haematology. 4(3). e114–e126. 154 indexed citations

10.

Jones, Jeffrey A., Tadeusz Robak, Małgorzata Wach, et al.. (2016). Updated results of a phase III randomized, controlled study of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 34(15_suppl). 7515–7515. 13 indexed citations

11.

Horak, Friedrich, Kamal D. Puri, Bart Steiner, et al.. (2016). Randomized phase 1 study of the phosphatidylinositol 3-kinase δ inhibitor idelalisib in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology. 137(6). 1733–1741. 27 indexed citations

12.

Horak, Christine E., Lajos Pusztai, Guan Xing, et al.. (2013). Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer. Clinical Cancer Research. 19(6). 1587–1595. 83 indexed citations

13.

Xing, Guan, Chang‐Yun Lin, Stephen Wooding, & Chao Xing. (2012). Blindly Using Wald's Test Can Miss Rare Disease‐Causal Variants in Case‐Control Association Studies. Annals of Human Genetics. 76(2). 168–177. 18 indexed citations

14.

Xing, Guan, Chang‐Yun Lin, & Chao Xing. (2011). A Comparison of Approaches to Control for Confounding Factors by Regression Models. Human Heredity. 72(3). 194–205. 6 indexed citations

15.

Xing, Chao, Nathan Morris, & Guan Xing. (2010). Distribution of model‐based multipoint heterogeneity lod scores. Genetic Epidemiology. 34(8). 912–916. 3 indexed citations

16.

Xing, Chao & Guan Xing. (2009). Power of selective genotyping in genome-wide association studies of quantitative traits. BMC Proceedings. 3(S7). S23–S23. 13 indexed citations

17.

Xing, Chao, et al.. (2007). Linkage studies of catechol-O-methyltransferase (COMT) and dopamine-beta-hydroxylase (DBH) cDNA expression levels. BMC Proceedings. 1(S1). S95–S95. 9 indexed citations

18.

Xing, Guan, Chao Xing, Qing Lu, & Robert C. Elston. (2007). A logistic mixture model for a family-based association study. BMC Proceedings. 1(S1). S44–S44. 1 indexed citations

19.

Xing, Chao, Ritwik Sinha, Guan Xing, Qing Lu, & Robert C. Elston. (2006). The Affected-/Discordant-Sib-Pair Design Can Guarantee Validity of Multipoint Model-Free Linkage Analysis of Incomplete Pedigrees When There Is Marker-Marker Disequilibrium. The American Journal of Human Genetics. 79(2). 396–401. 8 indexed citations

20.

Xing, Chao, Fredrick R. Schumacher, Guan Xing, et al.. (2005). Comparison of microsatellites, single-nucleotide polymorphisms (SNPs) and composite markers derived from SNPs in linkage analysis. BMC Genetics. 6(S1). S29–S29. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact